First Time Loading...

Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211

Watchlist Manager
Tibet Rhodiola Pharmaceutical Holding Co Logo
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Watchlist
Price: 47.35 CNY 0.62% Market Closed
Updated: Apr 28, 2024
Tibet Rhodiola Pharmaceutical Holding Co
/
Cash Flow Statement
/
Cash from Financing Activities

Tibet Rhodiola Pharmaceutical Holding Co
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tibet Rhodiola Pharmaceutical Holding Co
Cash from Financing Activities Peer Comparison

Comparables:
1099
S
601607
600998
C
600511
000963

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Cash from Financing Activities
-¥483.7m
CAGR 3-Years
-39%
CAGR 5-Years
-48%
CAGR 10-Years
-81%
Sinopharm Group Co Ltd
HKEX:1099
Cash from Financing Activities
-¥6.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Cash from Financing Activities
¥231.9m
CAGR 3-Years
N/A
CAGR 5-Years
-50%
CAGR 10-Years
N/A
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Cash from Financing Activities
-¥3.9B
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
China National Medicines Corp Ltd
SSE:600511
Cash from Financing Activities
-¥632.2m
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Huadong Medicine Co Ltd
SZSE:000963
Cash from Financing Activities
-¥1.2B
CAGR 3-Years
-18%
CAGR 5-Years
-4%
CAGR 10-Years
N/A

See Also

What is Tibet Rhodiola Pharmaceutical Holding Co's Cash from Financing Activities?
Cash from Financing Activities
-483.7m CNY

Based on the financial report for Dec 31, 2023, Tibet Rhodiola Pharmaceutical Holding Co's Cash from Financing Activities amounts to -483.7m CNY.

What is Tibet Rhodiola Pharmaceutical Holding Co's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-81%

Over the last year, the Cash from Financing Activities growth was -233%. The average annual Cash from Financing Activities growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been -39% over the past three years , -48% over the past five years , and -81% over the past ten years .

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.